American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's (NYSE: LLY) Zepbound delivering ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...

Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...

Share on Pinterest Tirzepatide (Zepbound ... issues such as nausea and diarrhea, occurring mainly during dose increases. Although both medications had similar overall safety profiles, semaglutide ...

Eli Lilly’s weight loss drug Zepbound ... issues such as nausea and diarrhea, occurring mainly during dose increases. Although both medications had similar overall safety profiles, semaglutide ...